Herbs, phytoestrogens, and other CAM therapies

Menopause

Volumn , Issue , 2007, Pages 683-690

  Fugh Berman, Adriane ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882873912     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369443-0/50061-2     Document Type: Chapter

References (88)

1. Barnes PM, Powell-Griner E, McFann K, Nahin RL Complementary and alternative medicine use among adults. United States, 2002. Adv Data 2004, 1-19.
2. Bair YA, Gold EB, Azari RA, et al. Use of conventional and comple-mentary health care during the transition to menopause: longitudinal results from the Study of Women's Health Across the Nation. Menopause 2005, 12:31-39.
3. Upchurch DM, Chyu L Use of complementary and alternative medi-cine among American women. Womens Health Issues 2005, 15:5-13.
4. Dessio W, Wade C, Chao M, et al. Religion, spirituality, and health-care choices of African-American women: results of a national survey. Ethn Dis 2004, 14:189-197.
5. Ziegler J Soybeans show promise in cancer prevention. JNCI 1994, 86:1666-1667.
6. Kaufman PB, Duke JA, Brielmann H, Boik J, Hoyt JE A comparative survey of leguminous plants as sources of the isoflavones genistein and daidzein: implications for human nutrition and health. J Alt Comple-ment Med 1997, 31:7-12.
7. Zubik L, Meydani M Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women. Am J Clin Nutr 2003, 77:1459-1465.
8. Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy supplementation on hot flushes. Ob Gyn 1998, 91:6-11.
9. Brzezinski A, Adlercreutz H, Shaoul R, et al. Short-term effects of phytoestrogen-rich diet on postmenopausal women. Menopause 1997, 4:89-94.
10. Burke GL, Legault C, Anthony M, et al. Soy protein and isoflavone effects on vasomotor symptoms in peri-and postmenopausal women: the Soy Estrogen Alternative Study. Menopause 2003, 10:147-153.
11. Van Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoes-trogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial. J Clin Oncol 2002, 20:1449-1455.
12. Murkies AL, Lombard C, Strauss BJG Dietary flour supplementation decreases postmenopausal hot flushes: effect of soy and wheat. Maturitas 1995, 21:189-195.
13. St Germain A, Peterson CT, Robinson JG, Alekel DL Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause 2001, 8:17-26.
14. Kotsopoulos D, Dalais FS, Liang YL, McGrath BP, Teede HJ The effects of soy protein containing phytoestrogens on menopausal symp-toms in postmenopausal women. Climacteric 2000, 3:161-167.
15. Dalais FS, Rice GE, Wahlquist ML, et al. Effects of dietary phytoes-trogens in postmenopausal women. Climacteric 1998, 1:124-129.
16. Washburn S, Burke GL, Morgan T, Anthony M Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999, 6:7-13.
17. Faure ED, Chantre P, Mares P Effects of a standardized soy extract on hot flushes: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2002, 9:329-334.
18. Han KK, Soares JM, Haidar MA, de Lima GR, Baracat EC Ben-efits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstet Gynecol 2002, 99:389-394.
19. Scambia G, Mango D, Signorile PG, et al. Clinical effects of a stan-dardized soy extract in postmenopausal women: a pilot study. Meno-pause 2000, 7:105-111.
20. Upmalis DH, Lobo R, Bradley L, et al. Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study. Menopause 2000, 7:236-242.
21. Quella SK, Loprinzi CL, Barton DL, et al. Evaluation of soy phytoes-trogens for the treatment of hot flashes in breast cancer survivors: a North Central Cancer Treatment Group Trial. J Clin Oncol 2000, 18:1068-1074.
22. Penotti M, Fabio E, Modena AB, et al. Effect of soy-derived isofla-vones on hot flushes, endometrial thickness, and the pulsatility index of the uterine and cerebral arteries. Fertil Steril 2003, 79:1112-1117.
23. Nikander E, Kilkkinen A, Metsa-Heikkila M, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients. Obstet Gynecol 2003, 101:1213-1220.
24. Secreto G, Chiechi LM, Amadori A, et al. Soy isoflavones and mela-tonin for the relief of climacteric symptoms: a multicenter, double-blind, randomized study. Maturitas 2004, 47:11-20.
25. Albertazzi P, Steel SA, Bottazzi M Effect of pure genistein on bone markers and hot flushes. Climacteric 2005, 8:371-379.
26. Wilcox G, Wahlqvist ML, Burger HG, Medley G Oestrogenic effects of plant foods in postmenopausal women. BMJ 1990, 301:905-906.
27. Baird DD, Umbach DM, Lansdell L, et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. J Clin Endocrinol Metab 1995, 80:685-690.
28. Adlercreutz H, Honjo H, Higashi A, et al. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 1991, 54:1093-1100.
29. Wu AH, Wan P, Hankin J, et al. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis 2002, 23:1491-1496.
30. Horn-Ross PL, John EM, Lee M, et al. Phytoestrogen consumption and breast cancer risk in a multiethnic population: the Bay Area Breast Cancer Study. Am J Epidemiol 2001, 154:434-441.
31. Dai Q, Franke AA, Yu H, et al. Urinary phytoestrogen excretion and breast cancer risk: evaluating potential effect modifiers endogenous estrogens and anthropometrics. Cancer Epidemiol Biomarkers Prev 2003, 12:497-502.
32. Lee HP, Gourley L, Duffy SW, et al. Dietary effects on breast cancer risk in Singapore. Lancet 1991, 337:1197-1200.
33. Goodman MT, Wilkems LR, Hankin JH, et al. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epi 1997, 146:294-306.
34. Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM A pilot study of the effects of phytoestrogen supplementation on postmeno-pausal endometrium J Soc. Gynecol Investig 2002, 9:238-242.
35. Murray MJ, Meyer WR, Lessey BA, et al. Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial. Menopause 2003, 10:456-464.
36. Anderson JW, Johnstone BM, Cook-Newe11 ME Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 1995, 33:276-282.
37. Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998, 68:1375S-1379S.
38. Strom BL, Schinnar R, Ziegler EE, et al. Exposure to soy-based for-mula in infancy and endocrinological and reproductive outcomes in young adulthood. J Am Med Assoc 2001, 286:2402-2403.
39. Massey LK, Palmer RG, Horner HTJ Oxalate content of soybean seeds (Glycine max: Leguminosae) , soyfoods, and other edible legumes. Agric Food Chem 2001, 49:4262-4266.
40. Messina M, Redmond G Effects of soy protein and soybean isofla-vones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid 2006, 16:249-258.
41. Bell DS, Ovalle F Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract 2001, 7:193-194.
42. Newton KM, Reed SD, LaCroix AZ, et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hor-mone therapy, or placebo: a randomized trial. Ann Intern Med 2006, 145:869-879.
43. Pockaj BA, Gallagher JG, Loprinzi CL, et al. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol 2006, 24:2836-2841.
44. Jacobson JS, Troxel AB, Evans J, et al. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer. J Clin Oncol 2001, 19:2739-2745.
45. Osmers R, Friede M, Liske E, et al. Efficacy and safety of isopropano-lic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005, 105:1074-1083.
46. Nappi R, Malavasi B, Brundu B, Facchinetti F Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low dose transdermal estradiol. Gynecol Endocrino 2005, 20:30-35.
47. Wuttke W, Sedlova-Wuttke D, Gorkow C The Cimicifuga prepara-tion BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003, S67-S77.
48. Warnecke G Beeinflussung klimakterischer Beschwerden durch ein Phytotherapeutikum: Erfolgreiche therapie mit Cimicifuga-Monocxtrakt (Influence of phytotherapy on men. Medizinische Welt 1985, 36:871-874.
49. Stoll W Phytotherapeutikum beeinflusst atrophisches Vaginalepithel: Doppelblindversuch Cimicifuga vs. Östrogenpräparat. Therapeutikon 1987, 1:23-31.
50. Lehmann-Willenbrock E, Riedel H Klinische und endokrinologische Untersuchengen zur Therapie ovarieller Ausfallserscheinungen nach Hysterektomie unter Belassung der Adnexe. Zentralblatt fur Gynakologie 1988, 110:611-618.
51. Lynch CR, Folkers ME, Hutson WR Fulminant hepatic failure asso-ciated with the use of black cohosh: a case report. Liver Transpl 2006, 12:989-992.
52. Cohen S, O'Connor AM, Hart J, Merel NH, Te Hs Autoimmune hepatitis associated with the use of black cohosh: a case study. Meno-pause 2004, 11:575-577.
53. Whiting P, Clouston A, Kerlin P Black Cohosh and other herbal remedies associated with acute hepatitis. MJA 2002, 177:440-443.
54. Hirata JD, Swiersz LM, Zell B, Small R, Ettinger B Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997, 68:981-986.
55. Fugh-Berman A Herb-drug interactions. Lancet 2000, 355:134-138.
56. Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994, 308:501-503.
57. Warnecke G, Pfaender H, Gerster G, Gracza E Wirksamkeit von Kava-Kava-Extrakt beim klimakterischen Syndrom. Z Phytother 1990, 11:81-86.
58. Warnecke G Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of Kava Extract WS 1490]. Fortschr Med 1991, 109(4):119-122.
59. Norton SA, Ruze P Kava dermopathy. J Am Acad Derm 1994, 31:89-97.
60. Tickel F, Baumuller HM, Seitz K, et al. Hepatitis induced by Kava (Piper methysticum rhizoma). J Hepatol 2003, 39:62-67.
61. Humberston CL, Akhtar J, Krenzelok EP Acute hepatitis induced by kava kiva. J Toxicol Clin Toxicol 2003, 41:109-113.
62. Wiklund IK, Mattsson L-A, Lindgren R, Limoni C Effects of a standardized ginseng extract on quality of life and physiological param-eters in symptomatic postmenopausal women: a double-blind, placebo-contro. Int J Clin Pharm Res 1999, XIX:89-99.
63. Greenspan EM Ginseng and vaginal bleeding. J Am Med Assoc 1983, 249:2018.
64. Hopkins MO, Androff L, Benninghoff AS Ginseng face cream and unexplained vaginal bleeding. Am J Ob Gyn 1988, 159:1121-1122.
65. Farese RV, Biglieri EG, Shackleton CHL, et al. Licorice-induced hypermineralocorticoidism. N Engl J Med 1991, 325:1223-1227.
66. Epstein MT, Espiner EA, Donald RA, Hughes H Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. BMJ 1977, 1:488-490.
67. Chandler RF Glycyrrhiza glabra. Adverse effects of herbal drugs 1992, vol 1. Springer-Verlag, Berlin. D. Smet PAGM, K. Keller, R. Hansel (Eds.).
68. Shintani S, Murase H, Tsukagoshi H, Shiigai T Glycyrrhizin (Licorice)- induced hypokalemic myopathy. Eur Neurol 1992, 32:44-51.
69. Chamberlain JJ, Abolnik IZ Pulmonary edema following a licorice binge. Western J Med 1997, 167:184-185.
70. M Wichtl Herbal drugs and phytopharmaceuticals 1994, Medpharm Scientific Publishers, Stuttgart.
71. Tice JA, Ettinger B, Ensrud K, et al. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial. JAMA 2003, 290:207-214.
72. Barber RJ, Templeman C, Morton T, Kelly GE, West L Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric 1999, 2:85-92.
73. Knight DC, Howes JB, Eden JA The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric 1999, 2:79-84.
74. van de Weijer PH, Barentsen R Isoflavones from red clover (Promen-sil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas 2002, 42:187-193.
75. Davis SR, Briganti EM, Chen RQ, et al. The effects of Chinese me-dicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial. Med J Aust 2001, 174:68-71.
76. Komesaroff PA, Black CV, Cable V, Sudhir K Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001, 4:144-150.
77. Leonetti HB, Longo S, Anasti JN Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss. Obstet Gynecol 1999, 94:225-228.
78. Wren BG, Champion SM, Willette K, Manga RZ, Eden JA Transder-mal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for post-menopausal wom. Menopause 2003, 10:13-18.
79. Fugh-Berman A, Bythrow J Bioidentical hormones for menopausal therapy: variation on a theme. J Gen Int Med 2007, published online March 7, 2007. http://www.springerlink.com/content/q4772464371784g2/.
80. Blatt MHG, Wiesbader H, Kupperman HS Vitamin E and climac-teric syndrome. Arch Intern Med 1953, 91:792-796.
81. Meydani SN, Meydani M, Blumberg JB, et al. Assessment of the safety of supplementation with different amounts of vitamin E in healthy older adults. Am J Clin Nutr 1998, 68:311-318.
82. Kim JM, White RH Effect of vitamin E on the anticoagulant response to warfarin. Am J Cardiol 1996, 77:545-546.
83. Wyon Y, Lindgren R, Lundeberg T, Hammar M Effects of acupunc-ture on climacteric vasomotor symptoms, quality of life, and urinary excretion of neuropeptides among postmenopausal women. Menopause 1995, 2:3-12.
84. Ernst E, White A Life-threatening adverse reactions after acupunc-ture? A systematic review. Pain 1997, 71:123-126.
85. Freedman RR, Woodward S Behavioral treatment of menopausal hot flashes:evaluation by ambulatory monitoring. Am J Obstet Gynecol 1992, 167:436-439.
86. Freedman RR, Woodward S, Brown B, Javaid JI, Pandey GN Bio-chemical and thermoregulatory effects of behavioral treatment for menopausal hot flashes. Menopause 1995, 2:211-218.
87. Irvin JH, Domar AD, Clark C, Zuttermeister PC, Friedman R The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynaecol 1996, 17:202-207.
88. Hammar M, Berg G, Lindgren R Does physical exercise influence the frequency of postmenopausal hot flushes?. Acta Obstet Gynecol Scand 1990, 69.